|
July 18, 2008 (New York, NY) - Proskauer Rose LLP, an international law firm with more than 750 lawyers worldwide, is proud to announce its representation of the William J. Clinton Foundation in its historic agreement with six international pharmaceutical companies, drug suppliers and drug ingredient producers to lower prices and ensure the new supply of malaria drugs for millions of people around the world.
Richard Zall, partner and Chair of Proskauer's Health Care Department, and Jaimi Gaffe, an associate in the Department, served as outside counsel to the Foundation in its negotiations with the international consortium of companies to establish an agreement to lower the price of a leading artemisinin-based combination therapy (ACT) for malaria by 30 percent and reduce the price volatility of artemisinin, the key raw material for ACTs, by 70 percent. The companies that comprise the consortium include Calyx, Cipla, Holleypharm, Ipca Laboratories, Mangalam Drugs and PIDI Standard.
The agreement will meet the growing global demand from up to 500 million people who require malaria treatment each year. The prices will be available to the 69 countries in Africa, Asia, Latin America and the Caribbean that make up the Clinton HIV/AIDS Initiative (CHAI) purchasing consortium.
Proskauer has represented the Clinton Foundation on a pro bono basis for several years. In addition to its work on the malaria agreements, the firm has represented the CHAI in its agreements with drug and diagnostic companies that have reduced prices for HIV/AIDS drugs and testing equipment by rationalizing the market for such products. Today, 1.4 million people are benefiting from medicines purchased under agreements negotiated by CHAI, several of which were done with the help of Proskauer. The firm has also advised the Clinton Foundation with respect to intellectual property issues raised by its drug purchasing programs, and has represented the Clinton Climate Initiative (CCI) in connection with its agreements with partners. CCI assists partner cities across the world in the development and implementation of large-scale projects that result in reductions in substantial energy use and greenhouse gas emissions.
Proskauer has one of the leading health care industry practices in the world. The Proskauer health industry practice group provides extensive health law and industry experience with the resources and depth of an international law firm to represent both well-established and emerging health care companies. Participants across the health care industry rely on the firm for the highest quality corporate and transactional, regulatory, reimbursement, litigation, labor, and tax representation. Proskauer's Health Care Department advises both investor-owned companies and not-for-profit organizations and understands the dynamics of the industry, from services and managed care to health information technology and life sciences.
About Proskauer Rose
Proskauer Rose, founded in 1875, is an international law firm providing a wide variety of legal services to clients worldwide from offices in Boca Raton, Boston, Chicago, Hong Kong, London, Los Angeles, New Orleans, New York, Newark, Paris, São Paulo, and Washington, D.C. The firm has wide experience in all areas of practice important to businesses and individuals including corporate finance, mergers and acquisitions, general commercial litigation, corporate governance matters, conducting internal corporate investigations, white collar criminal defense, private equity and fund formation, patent and intellectual property litigation and prosecution, labor and employment law, real estate transactions, bankruptcy and reorganizations, trusts and estates, and taxation. Its clients span industries including chemicals, entertainment, financial services, health care, information technology, insurance, internet, lodging and gaming, manufacturing, media and communications, pharmaceuticals, real estate investment, sports, and transportation. The firm can be found online at http://www.proskauer.com.
|
